143 related articles for article (PubMed ID: 33392907)
21. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
Eastham JA; Carver B; Katz J; Kattan MW
Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
[TBL] [Abstract][Full Text] [Related]
22. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
23. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
Cancer; 2007 Nov; 110(10):2202-9. PubMed ID: 17876838
[TBL] [Abstract][Full Text] [Related]
24. Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.
Pompe RS; Gild P; Karakiewicz PI; Bock LP; Schlomm T; Steuber T; Graefen M; Huland H; Tian Z; Tilki D
Prostate; 2018 Jun; 78(9):676-681. PubMed ID: 29570821
[TBL] [Abstract][Full Text] [Related]
25. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
Mithal P; Howard LE; Aronson WJ; Terris MK; Cooperberg MR; Kane CJ; Amling C; Freedland SJ
BJU Int; 2016 Feb; 117(2):244-8. PubMed ID: 26010160
[TBL] [Abstract][Full Text] [Related]
26. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
[TBL] [Abstract][Full Text] [Related]
27. Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.
Schulman AA; Howard LE; Tay KJ; Tsivian E; Sze C; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ; Polascik TJ
Cancer; 2017 Nov; 123(21):4122-4129. PubMed ID: 28662291
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration.
McKay RR; Sarkar RR; Kumar A; Einck JP; Garraway IP; Lynch JA; Mundt AJ; Murphy JD; Stewart TF; Yamoah K; Rose BS
Cancer; 2021 Feb; 127(3):403-411. PubMed ID: 33036065
[TBL] [Abstract][Full Text] [Related]
29. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
Moreira DM; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Boffetta P; Freedland SJ
Cancer; 2014 Jan; 120(2):197-204. PubMed ID: 24127391
[TBL] [Abstract][Full Text] [Related]
30. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
BJU Int; 2014 Nov; 114(5):661-6. PubMed ID: 24588774
[TBL] [Abstract][Full Text] [Related]
31. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
[TBL] [Abstract][Full Text] [Related]
32. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.
Amling CL; Riffenburgh RH; Sun L; Moul JW; Lance RS; Kusuda L; Sexton WJ; Soderdahl DW; Donahue TF; Foley JP; Chung AK; McLeod DG
J Clin Oncol; 2004 Feb; 22(3):439-45. PubMed ID: 14691120
[TBL] [Abstract][Full Text] [Related]
33. Agent Orange and long-term outcomes after radical prostatectomy.
Ovadia AE; Terris MK; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Abern MR
Urol Oncol; 2015 Jul; 33(7):329.e1-6. PubMed ID: 25998746
[TBL] [Abstract][Full Text] [Related]
34. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
Eastham JA; Kattan MW
J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
[TBL] [Abstract][Full Text] [Related]
35. Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
Wilkins LJ; Tosoian JJ; Reichard CA; Sundi D; Ranasinghe W; Alam R; Schwen Z; Reddy C; Allaf M; Davis JW; Chapin BF; Ross AE; Klein EA; Nyame YA
Cancer; 2021 May; 127(9):1425-1431. PubMed ID: 33721334
[TBL] [Abstract][Full Text] [Related]
36. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.
Jayachandran J; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):9-17. PubMed ID: 20056618
[TBL] [Abstract][Full Text] [Related]
37. Impact of surgical margin status on prostate-cancer-specific mortality.
Chalfin HJ; Dinizo M; Trock BJ; Feng Z; Partin AW; Walsh PC; Humphreys E; Han M
BJU Int; 2012 Dec; 110(11):1684-9. PubMed ID: 22788795
[TBL] [Abstract][Full Text] [Related]
38. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
Jayachandran J; Bañez LL; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ;
Cancer; 2009 Nov; 115(22):5263-71. PubMed ID: 19670453
[TBL] [Abstract][Full Text] [Related]
39. Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer.
Bolton DM; Ta A; Bagnato M; Muller D; Lawrentschuk NL; Severi G; Syme RR; Giles GG
World J Urol; 2014 Apr; 32(2):431-5. PubMed ID: 23824175
[TBL] [Abstract][Full Text] [Related]
40. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
